Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1032230398Not yet recruiting
Open-label, single-arm trial of propofol in None. Primary endpoint: Primary: Prediction Error (PEex) between end-tidal exhaled propofol and plasma propofol. Planned start Oct 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1032230398.